|
|
|
About Dr. Doug Berger
 The Director of the Tokyo Child and Adolescent Counseling Services is an American Board-Certified Psychiatrist, Douglas Berger, M.D., Ph.D. Dr. Berger is a graduate of New York Medical College where he also completed a 4-year residency program in psychiatry. Now based in Tokyo, Dr. Berger had served on the Faculty of the Albert Einstein College of Medicine Department of Psychiatry in New York as an Assistant Professor of Psychiatry.
Dr. Doug Berger has extensive experience working with children and adolescents both as a phychiatrist in New York as well as in seeing child and adolescent patients in therapy over many years in Japan. Dr. Berger is fluent in English, speaks native-level Japanese, and is conversational in Chinese.
Dr. Doug Berger's Japanese qualifications include a Ph.D. from the University of Tokyo School of Medicine(Registration No.11965), received for psychiatric research done while at the Tokyo University Department of Psychosomatic Medicine.
Dr. Berger's American Board Certification in Psychiatry (Certificate No. 34086) can be verified through the web site of the American Board of Medical Specialties (You first have to register to use this service, then enter name as: Douglas Berger in the search). You can also click here to see a cached version of Dr. Berger's Board Certification search results.
Dr. Berger's Doctorate (Ph.D.) from the University of Tokyo School of Medicine (Registration No.11965), received for psychiatric research done while at the Department of Psychosomatic Medicine at Tokyo University, is displayed along with Dr. Berger's Medical School Diploma, Psychiatry Residency Graduation Certificate, and Psychiatry Board Certification, in the therapy office.
Further information on Dr. Berger can be seen on his personal home page, and the Counseling Tokyo: Depression & Anxiety Specialists page.
Publications by Dr. Douglas Berger, psychiatrist in Tokyo
Berger D: DOUBLE-BLINDING AND BIAS IN MEDICATION AND COGNITIVE-BEHAVIORAL THERAPY TRIALS FOR MAJOR DEPRESSIVE DISORDER, F1000Research 2016, 4:638 (doi: 10.12688/f1000research.6953.2). U.S. National Library of Medicine version.
Berger D: DOUBLE BLINDING REQUIREMENT FOR VALIDITY CLAIMS IN COGNITIVE-BEHAVIORAL THERAPY INTERVENTION TRIALS FOR MAJOR DEPRESSIVE DISORDER. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial, F1000Research 2015, 4:639 (doi: 10.12688/f1000research.6954.1). U.S. National Library of Medicine version.
Articles by Douglas Berger, M.D., Ph.D. for Tokyo Families magazine.
Click here to see a full list of articles.
For more on Dr. Doug Berger, read his articles here.
|
|
日本語 Japanese
